Access to Investigational Treatments
Expanded access programs, also called EAPs, offer another possible path for people living with a serious or life-threatening illness to access investigational medical products. These may include drugs, biologic therapies or medical devices. EAPs provide treatment outside of clinical trials when no similar approved treatment exists and when joining a clinical trial is not possible. These programs, sometimes called “compassionate use,” may offer another option when standard treatments are no longer working or are not available to you.
Key Facts
- Expanded access programs (EAPs) may offer another path to receive treatment still in development when standard options are no longer effective.
- Approval to receive treatment through an EAP requires coordination with your healthcare provider, the treatment manufacturer, an Institutional Review Board (IRB) and the Federal Drug Administration (FDA).
- Costs for investigational treatments are often not covered by insurance.
Where to Find an Expanded Access Program
Your healthcare provider may be able to help you find an EAP. You can also search for EAPs online on the expanded access section of ClinicalTrials.gov.
For more information:
Page last updated: April 28, 2026
